US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BPTH

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
25/11/2024	15:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BPTH	Bio Path Holdings Inc
15/11/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Reports Third Quarter 2024 Financial Results	NASDAQ:BPTH	Bio Path Holdings Inc
13/11/2024	10:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:BPTH	Bio Path Holdings Inc
08/11/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024	NASDAQ:BPTH	Bio Path Holdings Inc
28/10/2024	15:37	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:BPTH	Bio Path Holdings Inc
28/10/2024	15:35	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BPTH	Bio Path Holdings Inc
28/10/2024	15:32	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BPTH	Bio Path Holdings Inc
23/10/2024	06:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BPTH	Bio Path Holdings Inc
22/10/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BPTH	Bio Path Holdings Inc
22/10/2024	14:11	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BPTH	Bio Path Holdings Inc
18/10/2024	16:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BPTH	Bio Path Holdings Inc
17/10/2024	15:37	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BPTH	Bio Path Holdings Inc
10/10/2024	16:24	GlobeNewswire Inc.	Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	NASDAQ:BPTH	Bio Path Holdings Inc
08/10/2024	19:00	GlobeNewswire Inc.	Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	NASDAQ:BPTH	Bio Path Holdings Inc
08/10/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity	NASDAQ:BPTH	Bio Path Holdings Inc
16/09/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Announces Publication in Biomedicines	NASDAQ:BPTH	Bio Path Holdings Inc
03/09/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:BPTH	Bio Path Holdings Inc
21/08/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors	NASDAQ:BPTH	Bio Path Holdings Inc
15/08/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Reports Second Quarter 2024 Financial Results	NASDAQ:BPTH	Bio Path Holdings Inc
14/08/2024	15:41	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BPTH	Bio Path Holdings Inc
08/08/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024	NASDAQ:BPTH	Bio Path Holdings Inc
01/08/2024	17:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BPTH	Bio Path Holdings Inc
08/07/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Provides Clinical Update and Expansion Plans	NASDAQ:BPTH	Bio Path Holdings Inc
14/06/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress	NASDAQ:BPTH	Bio Path Holdings Inc
03/06/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BPTH	Bio Path Holdings Inc
24/05/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress	NASDAQ:BPTH	Bio Path Holdings Inc
23/05/2024	16:00	GlobeNewswire Inc.	Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BPTH	Bio Path Holdings Inc
15/05/2024	06:50	IH Market News	U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop	NASDAQ:BPTH	Bio Path Holdings Inc
15/05/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings Reports First Quarter 2024 Financial Results	NASDAQ:BPTH	Bio Path Holdings Inc
08/05/2024	06:00	GlobeNewswire Inc.	Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024	NASDAQ:BPTH	Bio Path Holdings Inc

Showing the most relevant articles for your search:NASDAQ:BPTH

1 2 3 4 5 6 7 8 9 Próxima >

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

American Express

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones